Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes

Identifieur interne : 000096 ( PascalFrancis/Corpus ); précédent : 000095; suivant : 000097

Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes

Auteurs : WUXIONG CAO ; B. A. Myers-Powell ; T. J. Braciale

Source :

RBID : Pascal:94-0157851

Descripteurs français

English descriptors

Abstract

There are two immunogenic sites on the type A influenza A/Japan/57 (H2N2) hemagglutinin (HA) that can be recognized by class I major histocompatibility complex (MHC), H-2Kd-restricted cytolytic T lymphocytes (CTLs). One of these sites encompases two distinct partially overlapping epitopes, which span HA residues 204-212 and 210-219. During the analysis of the fine specificity of CTL clones directed to the HA 210-219 epitope, we found that one clone 40-2 also recognized the myeloma cell line P3x63-Ag8

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0022-1007
A02 01      @0 JEMEAV
A03   1    @0 J. exp. med.
A05       @2 179
A06       @2 1
A08 01  1  ENG  @1 Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes
A11 01  1    @1 WUXIONG CAO
A11 02  1    @1 MYERS-POWELL (B. A.)
A11 03  1    @1 BRACIALE (T. J.)
A14 01      @1 Univ. Virginia health sci. cent., dep. microbiology pathology, Beirne B. Carter cent. immunology res. @2 Charlottesville VA 22908 @3 USA
A20       @1 195-202
A21       @1 1994
A23 01      @0 ENG
A43 01      @1 INIST @2 601 @5 354000024461450170
A44       @0 0000
A45       @0 39 ref.
A47 01  1    @0 94-0157851
A60       @1 P
A61       @0 A
A64 01  1    @0 The Journal of experimental medicine
A66 01      @0 USA
C01 01    ENG  @0 There are two immunogenic sites on the type A influenza A/Japan/57 (H2N2) hemagglutinin (HA) that can be recognized by class I major histocompatibility complex (MHC), H-2Kd-restricted cytolytic T lymphocytes (CTLs). One of these sites encompases two distinct partially overlapping epitopes, which span HA residues 204-212 and 210-219. During the analysis of the fine specificity of CTL clones directed to the HA 210-219 epitope, we found that one clone 40-2 also recognized the myeloma cell line P3x63-Ag8
C02 01  X    @0 002A06C08
C03 01  X  FRE  @0 Lymphocyte T @5 01
C03 01  X  ENG  @0 T-Lymphocyte @5 01 @6 «T»-Lymphocyte
C03 01  X  SPA  @0 Linfocito T @5 01
C03 02  X  FRE  @0 Cytotoxicité @5 05
C03 02  X  ENG  @0 Cytotoxicity @5 05
C03 02  X  SPA  @0 Citotoxicidad @5 05
C03 03  X  FRE  @0 Reconnaissance @5 09
C03 03  X  ENG  @0 Recognition @5 09
C03 03  X  SPA  @0 Reconocimiento @5 09
C03 04  X  FRE  @0 Antigène @5 13
C03 04  X  ENG  @0 Antigen @5 13
C03 04  X  SPA  @0 Antígeno @5 13
C03 05  X  FRE  @0 Influenzavirus @2 NW @5 17
C03 05  X  ENG  @0 Influenzavirus @2 NW @5 17
C03 05  X  SPA  @0 Influenzavirus @2 NW @5 17
C03 06  X  FRE  @0 Immunomodulation @5 21
C03 06  X  ENG  @0 Immunomodulation @5 21
C03 06  X  SPA  @0 Inmunomodulación @5 21
C03 07  X  FRE  @0 Immunité croisée @5 43
C03 07  X  ENG  @0 Cross immunity @5 43
C03 07  X  SPA  @0 Inmunidad cruzada @5 43
C03 08  X  FRE  @0 Région variable @5 46
C03 08  X  ENG  @0 Variable region @5 46
C03 08  X  SPA  @0 Región variable @5 46
C03 09  X  FRE  @0 Chaîne peptidique lourde @5 49
C03 09  X  ENG  @0 Heavy peptide chain @5 49
C03 09  X  SPA  @0 Cadena peptídica pesada @5 49
C03 10  X  FRE  @0 Immunoglobuline @5 52
C03 10  X  ENG  @0 Immunoglobulins @5 52
C03 10  X  SPA  @0 Inmunoglobulina @5 52
C03 11  X  FRE  @0 Antigène histocompatibilité classe I @5 55
C03 11  X  ENG  @0 Class I histocompatibility antigen @5 55
C03 11  X  SPA  @0 Antígeno histocompatibilidad clase I @5 55
C03 12  X  FRE  @0 Souris @5 58
C03 12  X  ENG  @0 Mouse @5 58
C03 12  X  SPA  @0 Ratón @5 58
C03 13  X  FRE  @0 Réponse immune @5 61
C03 13  X  ENG  @0 Immune response @5 61
C03 13  X  SPA  @0 Respuesta inmune @5 61
C03 14  X  FRE  @0 Restriction histocompatibilité @4 INC @5 83
C07 01  X  FRE  @0 Orthomyxoviridae @2 NW
C07 01  X  ENG  @0 Orthomyxoviridae @2 NW
C07 01  X  SPA  @0 Orthomyxoviridae @2 NW
C07 02  X  FRE  @0 Virus @2 NW
C07 02  X  ENG  @0 Virus @2 NW
C07 02  X  SPA  @0 Virus @2 NW
C07 03  X  FRE  @0 Rodentia @2 NS
C07 03  X  ENG  @0 Rodentia @2 NS
C07 03  X  SPA  @0 Rodentia @2 NS
C07 04  X  FRE  @0 Mammalia @2 NS
C07 04  X  ENG  @0 Mammalia @2 NS
C07 04  X  SPA  @0 Mammalia @2 NS
C07 05  X  FRE  @0 Vertebrata @2 NS
C07 05  X  ENG  @0 Vertebrata @2 NS
C07 05  X  SPA  @0 Vertebrata @2 NS
N21       @1 080

Format Inist (serveur)

NO : PASCAL 94-0157851 INIST
ET : Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes
AU : WUXIONG CAO; MYERS-POWELL (B. A.); BRACIALE (T. J.)
AF : Univ. Virginia health sci. cent., dep. microbiology pathology, Beirne B. Carter cent. immunology res./Charlottesville VA 22908/Etats-Unis
DT : Publication en série; Niveau analytique
SO : The Journal of experimental medicine; ISSN 0022-1007; Coden JEMEAV; Etats-Unis; Da. 1994; Vol. 179; No. 1; Pp. 195-202; Bibl. 39 ref.
LA : Anglais
EA : There are two immunogenic sites on the type A influenza A/Japan/57 (H2N2) hemagglutinin (HA) that can be recognized by class I major histocompatibility complex (MHC), H-2Kd-restricted cytolytic T lymphocytes (CTLs). One of these sites encompases two distinct partially overlapping epitopes, which span HA residues 204-212 and 210-219. During the analysis of the fine specificity of CTL clones directed to the HA 210-219 epitope, we found that one clone 40-2 also recognized the myeloma cell line P3x63-Ag8
CC : 002A06C08
FD : Lymphocyte T; Cytotoxicité; Reconnaissance; Antigène; Influenzavirus; Immunomodulation; Immunité croisée; Région variable; Chaîne peptidique lourde; Immunoglobuline; Antigène histocompatibilité classe I; Souris; Réponse immune; Restriction histocompatibilité
FG : Orthomyxoviridae; Virus; Rodentia; Mammalia; Vertebrata
ED : T-Lymphocyte; Cytotoxicity; Recognition; Antigen; Influenzavirus; Immunomodulation; Cross immunity; Variable region; Heavy peptide chain; Immunoglobulins; Class I histocompatibility antigen; Mouse; Immune response
EG : Orthomyxoviridae; Virus; Rodentia; Mammalia; Vertebrata
SD : Linfocito T; Citotoxicidad; Reconocimiento; Antígeno; Influenzavirus; Inmunomodulación; Inmunidad cruzada; Región variable; Cadena peptídica pesada; Inmunoglobulina; Antígeno histocompatibilidad clase I; Ratón; Respuesta inmune
LO : INIST-601.354000024461450170
ID : 94-0157851

Links to Exploration step

Pascal:94-0157851

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Recognition of an immunoglobulin V
<sub>H</sub>
epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes</title>
<author>
<name sortKey="Wuxiong Cao" sort="Wuxiong Cao" uniqKey="Wuxiong Cao" last="Wuxiong Cao">WUXIONG CAO</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Univ. Virginia health sci. cent., dep. microbiology pathology, Beirne B. Carter cent. immunology res.</s1>
<s2>Charlottesville VA 22908</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Myers Powell, B A" sort="Myers Powell, B A" uniqKey="Myers Powell B" first="B. A." last="Myers-Powell">B. A. Myers-Powell</name>
</author>
<author>
<name sortKey="Braciale, T J" sort="Braciale, T J" uniqKey="Braciale T" first="T. J." last="Braciale">T. J. Braciale</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">94-0157851</idno>
<date when="1994">1994</date>
<idno type="stanalyst">PASCAL 94-0157851 INIST</idno>
<idno type="RBID">Pascal:94-0157851</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000096</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Recognition of an immunoglobulin V
<sub>H</sub>
epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes</title>
<author>
<name sortKey="Wuxiong Cao" sort="Wuxiong Cao" uniqKey="Wuxiong Cao" last="Wuxiong Cao">WUXIONG CAO</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Univ. Virginia health sci. cent., dep. microbiology pathology, Beirne B. Carter cent. immunology res.</s1>
<s2>Charlottesville VA 22908</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Myers Powell, B A" sort="Myers Powell, B A" uniqKey="Myers Powell B" first="B. A." last="Myers-Powell">B. A. Myers-Powell</name>
</author>
<author>
<name sortKey="Braciale, T J" sort="Braciale, T J" uniqKey="Braciale T" first="T. J." last="Braciale">T. J. Braciale</name>
</author>
</analytic>
<series>
<title level="j" type="main">The Journal of experimental medicine</title>
<title level="j" type="abbreviated">J. exp. med.</title>
<idno type="ISSN">0022-1007</idno>
<imprint>
<date when="1994">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">The Journal of experimental medicine</title>
<title level="j" type="abbreviated">J. exp. med.</title>
<idno type="ISSN">0022-1007</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antigen</term>
<term>Class I histocompatibility antigen</term>
<term>Cross immunity</term>
<term>Cytotoxicity</term>
<term>Heavy peptide chain</term>
<term>Immune response</term>
<term>Immunoglobulins</term>
<term>Immunomodulation</term>
<term>Influenzavirus</term>
<term>Mouse</term>
<term>Recognition</term>
<term>T-Lymphocyte</term>
<term>Variable region</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Lymphocyte T</term>
<term>Cytotoxicité</term>
<term>Reconnaissance</term>
<term>Antigène</term>
<term>Influenzavirus</term>
<term>Immunomodulation</term>
<term>Immunité croisée</term>
<term>Région variable</term>
<term>Chaîne peptidique lourde</term>
<term>Immunoglobuline</term>
<term>Antigène histocompatibilité classe I</term>
<term>Souris</term>
<term>Réponse immune</term>
<term>Restriction histocompatibilité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There are two immunogenic sites on the type A influenza A/Japan/57 (H2N2) hemagglutinin (HA) that can be recognized by class I major histocompatibility complex (MHC), H-2K
<sup>d</sup>
-restricted cytolytic T lymphocytes (CTLs). One of these sites encompases two distinct partially overlapping epitopes, which span HA residues 204-212 and 210-219. During the analysis of the fine specificity of CTL clones directed to the HA 210-219 epitope, we found that one clone 40-2 also recognized the myeloma cell line P3x63-Ag8</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0022-1007</s0>
</fA01>
<fA02 i1="01">
<s0>JEMEAV</s0>
</fA02>
<fA03 i2="1">
<s0>J. exp. med.</s0>
</fA03>
<fA05>
<s2>179</s2>
</fA05>
<fA06>
<s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Recognition of an immunoglobulin V
<sub>H</sub>
epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>WUXIONG CAO</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MYERS-POWELL (B. A.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>BRACIALE (T. J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Univ. Virginia health sci. cent., dep. microbiology pathology, Beirne B. Carter cent. immunology res.</s1>
<s2>Charlottesville VA 22908</s2>
<s3>USA</s3>
</fA14>
<fA20>
<s1>195-202</s1>
</fA20>
<fA21>
<s1>1994</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>601</s2>
<s5>354000024461450170</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>39 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>94-0157851</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>The Journal of experimental medicine</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>There are two immunogenic sites on the type A influenza A/Japan/57 (H2N2) hemagglutinin (HA) that can be recognized by class I major histocompatibility complex (MHC), H-2K
<sup>d</sup>
-restricted cytolytic T lymphocytes (CTLs). One of these sites encompases two distinct partially overlapping epitopes, which span HA residues 204-212 and 210-219. During the analysis of the fine specificity of CTL clones directed to the HA 210-219 epitope, we found that one clone 40-2 also recognized the myeloma cell line P3x63-Ag8</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A06C08</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Lymphocyte T</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>T-Lymphocyte</s0>
<s5>01</s5>
<s6>«T»-Lymphocyte</s6>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Linfocito T</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Cytotoxicité</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Cytotoxicity</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Citotoxicidad</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Reconnaissance</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Recognition</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Reconocimiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Antigène</s0>
<s5>13</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Antigen</s0>
<s5>13</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Antígeno</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Immunomodulation</s0>
<s5>21</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Immunomodulation</s0>
<s5>21</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Inmunomodulación</s0>
<s5>21</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Immunité croisée</s0>
<s5>43</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Cross immunity</s0>
<s5>43</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Inmunidad cruzada</s0>
<s5>43</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Région variable</s0>
<s5>46</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Variable region</s0>
<s5>46</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Región variable</s0>
<s5>46</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Chaîne peptidique lourde</s0>
<s5>49</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Heavy peptide chain</s0>
<s5>49</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Cadena peptídica pesada</s0>
<s5>49</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Immunoglobuline</s0>
<s5>52</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Immunoglobulins</s0>
<s5>52</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Inmunoglobulina</s0>
<s5>52</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Antigène histocompatibilité classe I</s0>
<s5>55</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Class I histocompatibility antigen</s0>
<s5>55</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Antígeno histocompatibilidad clase I</s0>
<s5>55</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Souris</s0>
<s5>58</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Mouse</s0>
<s5>58</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Ratón</s0>
<s5>58</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Réponse immune</s0>
<s5>61</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Immune response</s0>
<s5>61</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Respuesta inmune</s0>
<s5>61</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Restriction histocompatibilité</s0>
<s4>INC</s4>
<s5>83</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fN21>
<s1>080</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 94-0157851 INIST</NO>
<ET>Recognition of an immunoglobulin V
<sub>H</sub>
epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes</ET>
<AU>WUXIONG CAO; MYERS-POWELL (B. A.); BRACIALE (T. J.)</AU>
<AF>Univ. Virginia health sci. cent., dep. microbiology pathology, Beirne B. Carter cent. immunology res./Charlottesville VA 22908/Etats-Unis</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>The Journal of experimental medicine; ISSN 0022-1007; Coden JEMEAV; Etats-Unis; Da. 1994; Vol. 179; No. 1; Pp. 195-202; Bibl. 39 ref.</SO>
<LA>Anglais</LA>
<EA>There are two immunogenic sites on the type A influenza A/Japan/57 (H2N2) hemagglutinin (HA) that can be recognized by class I major histocompatibility complex (MHC), H-2K
<sup>d</sup>
-restricted cytolytic T lymphocytes (CTLs). One of these sites encompases two distinct partially overlapping epitopes, which span HA residues 204-212 and 210-219. During the analysis of the fine specificity of CTL clones directed to the HA 210-219 epitope, we found that one clone 40-2 also recognized the myeloma cell line P3x63-Ag8</EA>
<CC>002A06C08</CC>
<FD>Lymphocyte T; Cytotoxicité; Reconnaissance; Antigène; Influenzavirus; Immunomodulation; Immunité croisée; Région variable; Chaîne peptidique lourde; Immunoglobuline; Antigène histocompatibilité classe I; Souris; Réponse immune; Restriction histocompatibilité</FD>
<FG>Orthomyxoviridae; Virus; Rodentia; Mammalia; Vertebrata</FG>
<ED>T-Lymphocyte; Cytotoxicity; Recognition; Antigen; Influenzavirus; Immunomodulation; Cross immunity; Variable region; Heavy peptide chain; Immunoglobulins; Class I histocompatibility antigen; Mouse; Immune response</ED>
<EG>Orthomyxoviridae; Virus; Rodentia; Mammalia; Vertebrata</EG>
<SD>Linfocito T; Citotoxicidad; Reconocimiento; Antígeno; Influenzavirus; Inmunomodulación; Inmunidad cruzada; Región variable; Cadena peptídica pesada; Inmunoglobulina; Antígeno histocompatibilidad clase I; Ratón; Respuesta inmune</SD>
<LO>INIST-601.354000024461450170</LO>
<ID>94-0157851</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000096 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000096 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:94-0157851
   |texte=   Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021